3,3′-Diindolylmethane nanoencapsulation improves its antinociceptive action: Physicochemical and behavioral studies

• Published in: Colloids and surfaces, B, Biointerfaces Vol. 181; pp. 295 - 304
• Main Authors: Mattiazzi, Juliane, Marcondes Sari, Marcel Henrique, Brum, Taíne de Bastos, Araújo, Paulo César Oliveira, Nadal, Jéssica Mendes, Farago, Paulo Vítor, Nogueira, Cristina Wayne, Cruz, Letícia
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2019
• Subjects: Analgesics - chemistry; Analgesics - pharmacology; Animal model; Animals; Chemistry, Physical; Dose-Response Relationship, Drug; Edema - chemically induced; Edema - drug therapy; Formaldehyde; Freund's Adjuvant; Indole-3-carbinol; Indoles - chemistry; Indoles - pharmacology; Inflammation; Inflammation - chemically induced; Inflammation - drug therapy; Male; Mice; Nanocapsules - chemistry; Nanoparticles; Pain; Pain Measurement; Particle Size; Phytochemical; Surface Properties; Nanoparticles; Indole-3-carbinol; Animal model; Inflammation; Pain; Phytochemical
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2019.05.063

[Display omitted] •DIM nanocapsules have spherical shape and high thermal stability.•DIM nanocapsules elicited prolonged antinociceptive effect than the free compound form.•Both DIM forms caused no alteration in locomotor and exploratory activities. This study aimed to characterize the physicochemical properties of 3,3′-diindolylmethane (DIM)-loaded nanocapsules (NCs) as well as the antinociceptive effect using distinct animal models (hot plate test, formalin-induced nociception and complete Freud’s adjuvant induced paw inflammation). The DIM-loaded NCs (composed by primula oil and ethylcellulose) were characterized using differential scanning calorimetry, thermogravimetric analysis, Fourier-transformed infrared spectroscopy, X-ray diffractometry and scanning electron microscopy. The physicochemical characterization demonstrated that DIM could be molecularly dispersed into the NCs, whose size was nanometric with a spherical shape. An improvement in DIM thermal stability was achieved by its encapsulation and there were no interactions among the formula components. For the nociceptive evaluation, male adult Swiss mice were pretreated with the NCs or free DIM by the intragastric route at the dose of 10 mg/Kg (time-response curve), 5 or 2.5 mg/Kg (dose-response curve). The behavioral tests were performed over an experimental period of 0.5–8 h. Both free and nanoencapsulated DIM reduced the mechanical hypernociception induced by CFA, mitigated nociceptive behavior of formalin-induced neurogenic and inflammatory pain and increased paw withdrawal latency assessed by the hot-plate test. Importantly, the DIM nanoencapsulation promoted a rapid initiation and prolonged the bioactive antinociceptive action (up to 8 h) as well as reduced the effective dose in comparison to its free form. In summary, this study reported that the NCs had adequate nanometric size, increased DIM stability and its antinociceptive action in different animal models, suggesting that the formulation may be a possible therapeutic alternative to the management of pain and inflammatory-related pathologies.